https://orcid.org/0000-0002-4250-1036
Biologist from the Federal Rural University of Rio de Janeiro (1998), with a Master's degree in Biology from the Federal Rural University of Rio de Janeiro (2000), a doctorate in business (emphasis on Competitive Intelligence and Intellectual Property) from the Federal University of Rio de Janeiro (2008) , PhD in Plant Biotechnology from the Federal University of Rio de Janeiro (2011) and PhD in Intellectual Property and Innovation from the INPI Academy (2022). From March to August 2008, she was a scholarship holder for a Business Sandwich Doctorate in the Country by CNPq, working in the Pharmaceutical Industry, prospecting for medicines. In 2007, she was a Pro-Management Fellow at Far-Manguinhos, in the Coordination of Strategic Affairs, working in the area of Intellectual Property and Technological Innovation. He was a Technical Support Scholar in the Area of Biotechnology at the Agricultural Research Corporation of the State of Rio de Janeiro (Pesagro-Rio), with a Faperj Scholarship, from 2005 to 2007. He was a Patent Analyst at ANVISA until 2001 and a visiting specialist at the INCT Project of Neglected Diseases, coordinated by Dr. Carlos Morel (CDTS / FIOCRUZ) in 2016 and 2017. She has experience in the areas of Biotechnology, Intellectual Property, Innovation, and Biodiversity. She is currently an autonomous consultant for entities and companies such as Abifina, Fiocruz, CBPF, INT, LNCC, CETEM, UFRJ, Phytobios, Centroflora and others and a collaborating professor in the Specialization Course in Innovation Management at Fiocruz.
https://orcid.org/0000-0001-8897-4253
Lawyer, Master and Doctor in Intellectual Property and Innovation, WIPO Expert, author of books and articles. Technical-Technological Recognition Award by IPD-Farma (2017). Professional experience in legal consultancy and litigation since 1998.
The patent system is strategic for industries and research institutions. Although the Brazilian Industrial Property Law prohibits the patenting of living beings and their parts, there are loopholes to protect innovations with raw materials from biodiversity. In order to present a panorama of pharmaceutical inventions involving biodiversity, a search was conducted in the database of the Brazilian National Institute of Industrial Property of pharmaceutical products and processes with active ingredients derived from plants, animals and microorganisms. The results showed that companies and universities have filed patent applications claiming extracts, pharmaceutical compositions and innovative processes for obtaining them from biodiversity.
https://orcid.org/0000-0002-4250-1036
https://orcid.org/0000-0001-8897-4253
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Revista Fitos